Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients wonder whether taking semaglutide for a limited time—say 3 to 6 months—can deliver lasting weight loss results. Clinical data shows that GLP-1 receptor agonists like semaglutide do produce significant reductions in body weight during treatment periods, but the duration and structure of your therapy matters greatly for maintaining those gains after you stop.
How Semaglutide Works During Short-Term Treatment
Semaglutide activates GLP-1 receptors in your brain and gut, reducing hunger signals and increasing feelings of fullness after eating. This mechanism begins working within days of your first injection, which is why many patients report appetite changes and reduced calorie intake in the first week. The medication also slows gastric emptying—the rate at which food leaves your stomach—which extends satiety and helps control portion sizes naturally.
Short-term treatment typically refers to therapy lasting 3 to 12 months, during which your dose may gradually increase to reach therapeutic levels. Each dose adjustment is tailored to your individual response, and PlexusDx's compounded semaglutide injections allow for personalized dose escalation without price increases—your dose may need to go up, but your monthly cost remains stable at $149.
Weight Loss Results Expected in Short-Term Semaglutide Therapy
Clinical trials demonstrate that patients using semaglutide for 6 months typically achieve 5% to 10% body weight reduction, while those continuing 12 months or longer often reach 15% to 22% reductions. The amount of weight you lose depends on your starting weight, adherence to medication, diet quality, and physical activity level. Genetic factors also influence how effectively your body responds to GLP-1 activation—a reason why PlexusDx offers the Precision Peptide Genetic Test to identify your peptide-pathway predispositions.
Weight loss trajectory is usually steepest during months one through four, then gradually slows as your body adapts. This plateau doesn't mean treatment is failing; it reflects metabolic equilibrium at your new, lower weight. Stopping semaglutide before reaching your goal weight can result in regaining some weight, since appetite hormones typically rebound once the medication leaves your system.
What Happens When You Stop Short-Term Semaglutide
After discontinuing semaglutide, your GLP-1 receptor activity returns to baseline within 1 to 2 weeks, and appetite-regulating hormones like ghrelin begin rising again. Most patients experience increased hunger and food cravings if they haven't established permanent lifestyle changes during treatment. Research shows that approximately 50% of weight lost returns within one year of stopping medication, though this varies based on diet sustainability and exercise consistency.
The key to preventing weight regain is using your short-term semaglutide period to build durable eating habits, increase physical activity, and reduce ultra-processed foods. Some patients benefit from cycling off and back on therapy under medical supervision, while others transition to maintenance doses or other approaches. PlexusDx providers can discuss extended, intermittent, or modified protocols tailored to your weight loss goals and lifestyle capacity.
Is Short-Term Semaglutide Right for Your Weight Loss Plan
Short-term semaglutide therapy makes sense if you have 15% to 30% excess body weight to lose, can commit to behavioral changes during treatment, and prefer a defined treatment window over indefinite medication use. It's also appropriate for patients with specific life events—a wedding, vacation, or health milestone—who want rapid, medically supervised weight reduction. However, if you have severe obesity (BMI ≥ 35) or weight-related health conditions like diabetes or heart disease, your doctor may recommend longer treatment duration for sustained metabolic benefit.
The Precision Peptide Genetic Test offered by PlexusDx ($99 add-on after your first month) analyzes genetic variants in four key peptide pathways—GLP1R, GIPR, FTO, and MC4R—to predict which patients respond most robustly to GLP-1 therapy. Understanding your genetic predispositions helps you and your provider set realistic timelines and decide whether short-term, extended, or combination protocols align with your biology and goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use semaglutide for just three months and keep the weight off?
Three months of semaglutide can produce 5% to 10% weight loss, but maintaining that loss requires establishing sustainable eating and exercise habits during treatment. Without behavioral anchoring, most patients regain significant weight within 6 to 12 months after stopping. Extending treatment to 6 months or longer, combined with lifestyle coaching, significantly improves long-term weight stability.
What clinical data supports short-term GLP-1 therapy effectiveness?
Landmark trials show semaglutide reduces body weight by 10% to 16% over 68 weeks of continuous treatment. Shorter treatment periods (12-16 weeks) demonstrate weight loss of 4% to 8%, with most reductions occurring in the first 8 weeks. Real-world data from compounded GLP-1 programs shows similar outcomes when patients maintain treatment duration and medication adherence.
How much does short-term semaglutide treatment cost with PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month, with no your dose may need to go up - your price won't adjusts upward during treatment. A 6-month course costs $894 ($149 × 6), and a 12-month course costs $1,788. Pricing remains flat across all dose levels, and treatment is HSA/FSA-eligible with no insurance required or membership fees.
Are short-term semaglutide injections safe for everyone?
Semaglutide is contraindicated in people with personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia Type 2. Common side effects—nausea, constipation, and reduced appetite—are usually mild and diminish over weeks. Serious complications are rare but can include pancreatitis or gallbladder issues. PlexusDx requires medical consultation before dispensing compounded semaglutide to ensure safety and appropriateness.
Does the Precision Peptide Genetic Test help predict short-term treatment success?
Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways to identify which patients have genetic predispositions favoring robust GLP-1 response. High responders often achieve goal weight faster on shorter treatment timelines, while moderate responders may benefit from extended or combination therapy protocols.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Better to Take GLP-1 at Night or Morning?
Does Mounjaro Have Less Side Effects Than Ozempic? Exploring the Differences